{"gao_id": "GAO-16-99", "published": "2015-10-23T12:00:00Z", "released": "2015-11-23T07:00:00Z", "summary": "", "title": "Biosurveillance: DHS Should Not Pursue BioWatch Upgrades or Enhancements Until System Capabilities Are Established", "topics": ["Deoxyribonucleic acid", "Best practices", "Commercial off the shelf", "Homeland Security", "Biosurveillance", "Homeland security", "Genetics", "Anthrax", "Aerosols", "Developmental testing", "Agency evaluations"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-16-99", "versions": [{"title": "Highlights Page (1 page)", "url": "https://www.gao.gov/assets/gao-16-99-highlights.pdf"}, {"title": "Full Report (101 pages)", "url": "https://www.gao.gov/assets/gao-16-99.pdf"}, {"title": "Accessible PDF (106 pages)", "url": "https://www.gao.gov/assets/680/673531.pdf"}]}